Postmenopausal hormone therapy: risks and benefits

The 2012 Hormone Therapy Position Statement of The North American Menopause Society

(2016)   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy

(2014) Heli Lyytinen et al.   OBSTETRICS AND GYNECOLOGY

Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis

(2013) Catherine MacLean et al.   ANNALS OF INTERNAL MEDICINE

Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendations

(2013) Heidi D. Nelson et al.   ANNALS OF INTERNAL MEDICINE

Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Hormone Therapy and Different Ovarian Cancers: A National Cohort Study

(2012) L. S. Morch et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Hormone Therapy, Estrogen Metabolism, and Risk of Breast Cancer in the Women's Health Initiative Hormone Therapy Trial

(2012) R. H. Mackey et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial

(2012) Mia Fahlén et al.   EUROPEAN JOURNAL OF CANCER

A Decade after the Women's Health Initiative—The Experts Do Agree

(2012) Cynthia A. Stuenkel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Estrogen Plus Progestin and Colorectal Cancer Incidence and Mortality

(2012) Michael S. Simon et al.   JOURNAL OF CLINICAL ONCOLOGY

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

(2012) Garnet L Anderson et al.   LANCET ONCOLOGY

Phytoestrogens for menopausal symptoms: A review

(2012) John A. Eden   MATURITAS

Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study

(2012) H. Shao et al.   NEUROLOGY

Hormone Treatment, Estrogen Receptor Polymorphisms and Mortality: A Prospective Cohort Study

(2012) Joanne Ryan et al.   PLoS One

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

(2012) L. L. Schierbeck et al.   BMJ-British Medical Journal

Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk

(2012) Ying Huang et al.   Genome Medicine

Menopausal hot flushes and vascular health

(2011) Pauliina Tuomikoski et al.   ANNALS OF MEDICINE

Hormone therapy use and mammographic density in postmenopausal Norwegian women

(2011) Elisabeth Couto et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials

(2011) Carolyn J. Crandall et al.   BREAST CANCER RESEARCH AND TREATMENT

Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy

(2011) Andrea Z. LaCroix   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy

(2011) V. Beral et al.   JNCI-Journal of the National Cancer Institute

EMAS position statement: Managing menopausal women with a personal or family history of VTE

(2011) Florence Tremollieres et al.   MATURITAS

EMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis

(2011) Santiago Palacios et al.   MATURITAS

Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healing

(2011) Audrey Billon-Galés et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A “window of opportunity:” The reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent

(2010) Howard N. Hodis et al.   BRAIN RESEARCH

Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women

(2010) Valérie Olié et al.   CURRENT OPINION IN HEMATOLOGY

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

(2010) Rowan T. Chlebowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement

(2010) Richard J. Santen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lung Cancer Among Postmenopausal Women Treated With Estrogen Alone in the Women's Health Initiative Randomized Trial

(2010) Rowan T. Chlebowski et al.   JNCI-Journal of the National Cancer Institute

Sex steroids to maintain cognitive function in women after the menopause: A meta-analyses of treatment trials

(2010) Eef Hogervorst et al.   MATURITAS

Women's voices in the menopause: Results from an international survey on vaginal atrophy

(2010) Rossella E. Nappi et al.   MATURITAS

EMAS position statement: Managing women with premature ovarian failure

(2010) Svetlana Vujovic et al.   MATURITAS

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club

(2010) J.-J. Body et al.   OSTEOPOROSIS INTERNATIONAL

Development and use of FRAX® in osteoporosis

(2010) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD

(2010) Daniel H.S. Silverman et al.   PSYCHONEUROENDOCRINOLOGY

Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin

(2009) Celeste Leigh Pearce et al.   CANCER

Predicting the 30-Year Risk of Cardiovascular Disease

(2009) Michael J. Pencina et al.   CIRCULATION

Different cardiovascular effects of progestins according to structure and activity

(2009) A. Nath et al.   CLIMACTERIC

Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: A systematic review and meta-analysis

(2009) Konstantinos A. Toulis et al.   CLINICAL THERAPEUTICS

Aging, Estrogens, and Episodic Memory in Women

(2009) Victor W. Henderson   Cognitive and Behavioral Neurology

Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?

(2009) Agnès Fournier et al.   JOURNAL OF CLINICAL ONCOLOGY

Newer Antidepressants and Gabapentin for Hot Flashes: An Individual Patient Pooled Analysis

(2009) Charles L. Loprinzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy, Safety, and Tolerability of Low-Dose Hormone Therapy in Managing Menopausal Symptoms

(2009) R. D. Langer   Journal of the American Board of Family Medicine

Vaginal Estrogen Therapy for the Treatment of Atrophic Vaginitis

(2009) Catherine Lynch   JOURNAL OF WOMENS HEALTH

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

(2009) Rowan T Chlebowski et al.   LANCET

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

(2009) Peter Kenemans et al.   LANCET ONCOLOGY

Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

(2009) Rowan T. Chlebowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endogenous and Exogenous Estrogen, Cognitive Function, and Dementia in Postmenopausal Women: Evidence from Epidemiologic Studies and Clinical Trials

(2009) Elizabeth Barrett-Connor et al.   SEMINARS IN REPRODUCTIVE MEDICINE

Conjugated Equine Estrogens and Breast Cancer Risk in the Women's Health Initiative Clinical Trial and Observational Study

(2008) R. L. Prentice et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women

(2008) R. L. Prentice et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer

(2008) M. Hickey et al.   ANNALS OF ONCOLOGY

Postmenopausal Hormone Therapy and Stroke

(2008) Francine Grodstein et al.   ARCHIVES OF INTERNAL MEDICINE

Racial disparities in recurrence among patients with early-stage endometrial cancer

(2008) G. Larry Maxwell et al.   CANCER

A survey among breast cancer survivors: treatment of the climacteric after breast cancer

(2008) C. Antoine et al.   CLIMACTERIC

Observational Studies Analyzed Like Randomized Experiments

(2008) Miguel A. Hernán et al.   EPIDEMIOLOGY

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis

(2008) Gillian M. Sare et al.   EUROPEAN HEART JOURNAL

Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors

(2008) L. Holmberg et al.   JNCI-Journal of the National Cancer Institute

The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy

(2008) A. Gompel et al.   MATURITAS

Hormone replacement therapy use and the risk of stroke

(2008) Christel Renoux et al.   MATURITAS

The Effects of Tibolone in Older Postmenopausal Women

(2008) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review

(2007) Barbara B. Sherwin et al.   FRONTIERS IN NEUROENDOCRINOLOGY